Literature DB >> 2210462

Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus.

P Parrilla1, A Ortiz, L F Martinez de Haro, J L Aguayo, P Ramirez.   

Abstract

A manometric study to determine the role of gastro-oesophageal reflux in Barrett's oesophagus was performed on 20 patients with Barrett's oesophagus and 53 patients with reflux oesophagitis without Barrett's oesophagus (25 with mild oesophagitis and 28 with severe oesophagitis). For the same reason, the 20 patients with Barrett's oesophagus also underwent 24 hour continuous oesophageal pH monitoring, and the results obtained were compared with those of 20 oesophagitis patients without Barrett's oesophagus (10 with mild oesophagitis and 10 with severe oesophagitis). The manometric results show that the motor changes found in the Barrett's group are specific but similar to the motor dysfunction associated with reflux oesophagitis. Motor anomalies are probably related more to the inflammatory process in the oesophageal wall than to the metaplastic changes themselves. The pH monitoring results show that while reflux in the Barrett's oesophagus patients was greater overall than in the oesophagitis group without Barrett's oesophagus, the changes are similar when the results are compared with the severe oesophagitis group. In conclusion there are other factors besides gastro-oesophageal reflux involved in the pathogenesis of Barrett's oesophagus.

Entities:  

Mesh:

Year:  1990        PMID: 2210462      PMCID: PMC1378648          DOI: 10.1136/gut.31.9.964

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  The lower esophagus lined by columnar epithelium. Its association with hiatal hernia, ulcer, stricture, and tumor.

Authors:  R H ADLER
Journal:  J Thorac Cardiovasc Surg       Date:  1963-01       Impact factor: 5.209

2.  Barrett syndrome. Case report with discussion about concepts of pathogenesis.

Authors:  M C GOLDMAN; R C BECKMAN
Journal:  Gastroenterology       Date:  1960-07       Impact factor: 22.682

3.  Enzyme and ultrastructural characteristics of esophageal columnar epithelium.

Authors:  M M Berenson; J J Herbst; J W Freston
Journal:  Am J Dig Dis       Date:  1974-10

4.  [Does alcohol favour the development of Barret's syndrome (endobrachy-oesophagus) (author's transl)?].

Authors:  G A Martini; M Wienbeck
Journal:  Dtsch Med Wochenschr       Date:  1974-03-08       Impact factor: 0.628

5.  Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux.

Authors:  L F Johnson; T R Demeester
Journal:  Am J Gastroenterol       Date:  1974-10       Impact factor: 10.864

6.  Conservative operations for peptic esophagitis with stenosis in columnar-lined lower esophagus.

Authors:  A P Naef; M Savary
Journal:  Ann Thorac Surg       Date:  1972-06       Impact factor: 4.330

7.  The "Barrett syndrome" (the columnar-lined lower oesophagus): an acquired condition secondary to reflux oesophagitis. A case report with discussion of pathogenesis.

Authors:  J F Halvorsen; B K Semb
Journal:  Acta Chir Scand       Date:  1975

8.  Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy.

Authors:  S R Hamilton; J H Yardley
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

9.  Columnar cell-lined esophagus: assessment of etiology and treatment. A 22 year experience.

Authors:  J Borrie; L Goldwater
Journal:  J Thorac Cardiovasc Surg       Date:  1976-06       Impact factor: 5.209

10.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas.

Authors:  A P Naef; M Savary; L Ozzello
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209

View more
  12 in total

Review 1.  How should Barrett's ulceration be treated?

Authors:  J H Peters; K K Wang
Journal:  Surg Endosc       Date:  2004-01-12       Impact factor: 4.584

Review 2.  Natural history of Barrett's esophagus.

Authors:  Rao Milind; Stephen E Attwood
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

3.  Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation.

Authors:  Kumar Krishnan; John E Pandolfino; Peter J Kahrilas; Laurie Keefer; Lubomyr Boris; Srinadh Komanduri
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

Review 4.  Epidemiology of gastro-esophageal reflux disease.

Authors:  P J Howard; R C Heading
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

5.  Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux.

Authors:  L Martinez de Haro ; A Ortiz; P Parrilla; V Munitiz; J Molina; J Bermejo; A Rios
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

6.  Multivariate analysis of pathophysiological factors in reflux oesophagitis.

Authors:  G Cadiot; A Bruhat; D Rigaud; T Coste; A Vuagnat; Y Benyedder; T Vallot; D Le Guludec; M Mignon
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

7.  The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus.

Authors:  M R Gray; R J Donnelly; A N Kingsnorth
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

8.  24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus.

Authors:  C S Neumann; B T Cooper
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

9.  Characteristics of acid reflux in Barrett's esophagus.

Authors:  Junying Xu; Jie Chen; Xiaohua Hou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

10.  Non-invasive detection of gastro-oesophageal reflux using an ambulatory system.

Authors:  N Washington; H A Moss; C Washington; J L Greaves; R J Steele; C G Wilson
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.